4.7 Article

SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates

Journal

NATURE IMMUNOLOGY
Volume 13, Issue 3, Pages 223-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ni.2236

Keywords

-

Categories

Funding

  1. Agence Nationale de la Recherche sur le SIDA et les Hepatites Virales
  2. SIDACTION
  3. Fondation de France, Mairie de Paris
  4. American Foundation for AIDS Research
  5. US National Institutes of Health [AI049781, A1077401, A1067059, F31 GM095190]
  6. European Research Council [250333]
  7. Paris Diderot University
  8. Ministere de l'Enseignement Superieur et de la Recherche

Ask authors/readers for more resources

SAMHD1 restricts the infection of dendritic and other myeloid cells by human immunodeficiency virus type 1 (HIV-1), but in lentiviruses of the simian immunodeficiency virus of sooty mangabey (SIVsm)-HIV-2 lineage, SAMHD1 is counteracted by the virion-packaged accessory protein Vpx. Here we found that SAMHD1 restricted infection by hydrolyzing intracellular deoxynucleoside triphosphates (dNTPs), lowering their concentrations to below those required for the synthesis of the viral DNA by reverse transcriptase (RT). SAMHD1-mediated restriction was alleviated by the addition of exogenous deoxynucleosides. An HIV-1 with a mutant RT with low affinity for dNTPs was particularly sensitive to SAMHD1-mediated restriction. Vpx prevented the SAMHD1-mediated decrease in dNTP concentration and induced the degradation of human and rhesus macaque SAMHD1 but had no effect on mouse SAMHD1. Nucleotide-pool depletion could be a general mechanism for protecting cells from infectious agents that replicate through a DNA intermediate.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available